We are live on
!
Find out more
SAM
Stenahm Asset Management Portfolio holdings
AUM
$206M
1-Year Est. Return
42.47%
This Fund
S&P 500
This Quarter
Est. Return
+9.79%
1 Year Est. Return
+42.47%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$163M
AUM Growth
+$21.2M
(+15%)
Cap. Flow
+$8.98M
Cap. Flow
% of AUM
5.51%
Top 10 Holdings %
Top 10 Hldgs %
62.99%
Holding
33
New
7
Increased
3
Reduced
6
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teck Resources
TECK
|
+$8.17M |
| 2 |
Applied Materials
AMAT
|
+$7.45M |
| 3 |
Analog Devices
ADI
|
+$5.67M |
| 4 |
United Therapeutics
UTHR
|
+$3.68M |
| 5 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
+$3.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Aclaris Therapeutics
ACRS
|
+$7.14M |
| 2 |
Equinix
EQIX
|
+$5.98M |
| 3 |
SCR
Score Media and Gaming Inc. Class A Subordinate Voting Shares
SCR
|
+$3.89M |
| 4 |
Fate Therapeutics
FATE
|
+$2.79M |
| 5 |
Ascendis Pharma A/S
ASND
|
+$2.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.4% |
| 2 | Financials | 18.68% |
| 3 | Communication Services | 17.93% |
| 4 | Healthcare | 9.92% |
| 5 | Consumer Discretionary | 8.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Beyond Meat
BYND
$274M
| $16K | 0.01% |
100
| – | – |
|
|
27
Aclaris Therapeutics
ACRS
$714M
| – | – |
-283,500
| Closed | -$7.14M |
|
|
ADVM
28
DELISTED
Adverum Biotechnologies
ADVM
| – | – |
-11,100
| Closed | -$1.09M |
|
|
29
Ascendis Pharma A/S
ASND
$16.6B
| – | – |
-19,400
| Closed | -$2.5M |
|
30
Sprott Physical Gold and Silver Trust
CEF
$7.4B
| – | – |
-46,400
| Closed | -$806K |
|
|
31
Fate Therapeutics
FATE
$270M
| – | – |
-33,900
| Closed | -$2.79M |
|
|
GRTS
32
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| – | – |
-150,000
| Closed | -$1.42M |
|
|
SCR
33
DELISTED
Score Media and Gaming Inc. Class A Subordinate Voting Shares
SCR
| – | – |
-145,000
| Closed | -$3.89M |
|
Similar funds
AFTS
SCM
AFT
LPFG
SC
ASI
TS
ACM
Stenahm Asset Management's Q2 2021 Portfolio in Review
As of Q2 2021, Stenahm Asset Management held 33 positions worth $163M, up 15% from $142M the previous quarter. Its ten largest holdings account for 63% of the portfolio.
Stenahm Asset Management deployed $8.98M of net new capital in Q2 2021, opening 7 new positions and adding to 3 existing holdings. Its largest new stake was Teck Resources: 359,000 shares worth $8.27M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 24% a quarter earlier, followed by Financials and Communication Services.
On the sell side, the largest reduction was Equinix, an estimated $5.98M trimmed.
- Stenahm Asset Management's largest Q2 2021 buy was Teck Resources: 359,000 shares worth $8.27M.
- Stenahm Asset Management added most to Visa in Q2 2021, an estimated $2.97M increase.
- Stenahm Asset Management's biggest Q2 2021 reduction was Equinix, cutting an estimated $5.98M.
- Stenahm Asset Management fully exited Aclaris Therapeutics in Q2 2021, selling an estimated $7.14M.
- Stenahm Asset Management's ten largest holdings make up 63% of its $163M portfolio in Q2 2021.
- Stenahm Asset Management opened 7 new positions and closed 7 in Q2 2021.
- Stenahm Asset Management's portfolio value rose 15% quarter-over-quarter to $163M.
Based on Stenahm Asset Management's 13F filing for Q2 2021, filed 13 Aug 2021.